Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Standard of Care × Gynecologic × Clear all

Phase

Phase NA 21 Phase 2 5 Phase 3 2 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Thoracic 2 Breast 2 Tumor-Agnostic 1 Other hematologic neoplasm 1 Lymphoid 1 Head & Neck 1 Gynecologic 1 Genitourinary 1 CNS 1

Conditions

Peritoneal Neoplasms 1

Interventions

Paclitaxel 12 Carboplatin 11 Cisplatin 9 Letrozole 6 Drug Therapy 6 liposomal doxorubicin 5 Megestrol Acetate 4 Bevacizumab 4 spartalizumab 3 Topotecan 3 Taxes 3 Medroxyprogesterone Acetate 3 olaparib 2 niraparib 2 atezolizumab 2 Methotrexate 2 Magnetic Resonance Spectroscopy 2 Imiquimod 2 Hyperthermic Intraperitoneal Chemotherapy 2 Gonadotropin-Releasing Hormone 2 Gemcitabine 2 Doxorubicin 2 1-dodecylpyridoxal 2 trametinib 1 sintilimab 1 saracatinib 1 ricin A-GnRH conjugate 1 pertuzumab 1 pembrolizumab 1 pegfilgrastim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07001748 2026-03-23

STOPGAP II

Eastern Cooperative Oncology Group

Phase 2/3 Recruiting

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡